Product Recall Issued for Scott & Jon’s Shrimp Scampi with Linguini
The U.S. Food and Drug Administration (FDA) has announced a voluntary recall initiated by Demers Food Group for specific batches of Scott & Jon’s Shrimp Scampi with Linguini. This recall is due to potential contamination with Listeria monocytogenes, a bacterium that poses significant health risks.
Reason for Recall
The recall was triggered when Nateโs Fine Foods, based in Roseville, California, informed Demers Food Group that the shrimp scampi products contained a recalled batch of linguini. This action underscores the importance of food safety and the need for immediate corrective measures when potential hazards are identified.
Health Risks
Listeria monocytogenes is known to cause listeriosis, a serious infection that can be particularly dangerous for pregnant women, newborns, the elderly, and individuals with weakened immune systems. Symptoms of listeriosis can include fever, muscle aches, nausea, and diarrhea. In severe cases, the infection may lead to complications such as meningitis or septicemia.
Recommended Actions for Consumers
Consumers who have purchased Scott & Jon’s Shrimp Scampi with Linguini are advised to check their refrigerators and freezers for the affected product. If found, they should not consume it and are encouraged to discard it immediately. For those who have questions or concerns, contacting the retailer from which the product was purchased is recommended for further assistance.
Importance of Recalls for Public Safety
Food recalls play a crucial role in ensuring public safety by preventing contaminated products from reaching consumers. The FDA routinely collaborates with food companies to mitigate risks and safeguard public health. It is essential for consumers to stay informed about recalls and to take appropriate actions to protect themselves.
Reporting Adverse Effects
Individuals who suspect they have experienced health issues due to the consumption of the recalled product are urged to report their experiences to the FDA. This can be done through the FDA’s MedWatch program, which allows consumers to submit reports of adverse effects and product complaints. The reporting of adverse effects not only assists in ensuring accountability but may also help prevent further incidents.
For more information on this recall, including details about the specific batches affected, please visit the official FDA announcement at FDA Recalls.
Source : www.fda.gov
